1.
Blumel L, Bernardi F, Picard D, Diaz JT, Jepsen VH, Hasselmann R, Schliehe-Diecks J, Bartl J, Qin N, Bornhauser B, Bhatia S, Marovka B, Marsaud V, Dingli F, Loew D, Stanulla M, Bourqin J-P, Borkhardt A, Remke M, Ayrault O, Fischer U. Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia. haematol [Internet]. 2020Sep.10 [cited 2024May22];. Available from: https://haematologica.org/article/view/haematol.2023.283928